Dr. Kenneth Frederick Grossmann, MD
- Medicare services, 2024
- 57
- Medicare patients, 2024
- 31
- Part D claims, 2024
- 111
- Publications
- 43
- Clinical trials
- 10
- Practice address
- 4805 NE Glisan Street, Portland, OR 97213
- Practice phone
- Call (503) 215-1111
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Grossmann's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Kenneth Frederick Grossmann is a medical oncologist in Portland, Oregon
Dr. Grossmann practices at Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services.
Dr. Grossmann's NPI, 1083827455, was assigned on May 8, 2007. Dr. Grossmann graduated from Oregon Health Sciences University School of Medicine in 2004. Dr. Grossmann holds Utah license 6731091-1205.
- NPI
- 1083827455NPI Registry (opens in a new tab)
- NPI enumeration date
- May 8, 2007
- NPI status
- Active
- Practice phone
- (503) 215-1111
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 48
- Medical school graduation
- 2004
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Kenneth Frederick Grossmann practices at Providence Portland Medical Center in Portland, Oregon
Dr. Grossmann's primary practice is Providence Portland Medical Center, at 4805 NE Glisan Street, Portland, OR 97213 in Multnomah County. The practice phone is (503) 215-1111.
- Providence Portland Medical Center4805 NE Glisan Street, Portland, OR 97213 · Multnomah CountyPhone(503) 215-1111
Source: Dmand AI Affiliation Data
Dr. Kenneth Frederick Grossmann is affiliated with 1 site of care and 1 medical group
Dr. Grossmann's primary practice is Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services. The medical group on file is Providence Medical Group, Oregon.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Kenneth Frederick Grossmann's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grossmann practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Providence Portland Medical Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Providence Health & Services and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Kenneth Frederick Grossmann is one of 91 medical oncologists in Oregon
Medical oncology is Dr. Grossmann's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Grossmann is licensed in Utah.
Specialties and state licenses
- Medical oncology, UtahPrimary
Medical oncologists near Dr. Grossmann
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Kenneth Frederick Grossmann billed Medicare for 57 services in 2024
CMS data shows 57 Medicare services from Dr. Grossmann across 2 procedure codes in 2024, for 31 Medicare patients. Medicare paid $3,585 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Grossmann's Medicare services by type, 2021 to 2024
- 2021
- 2024
- Other services
- 2021: 02024: 29
- Office and hospital visits
- 2021: 2012024: 2886%
Dr. Grossmann compared with the Oregon median for medical oncologists, 2024
- Dr. Grossmann
- Oregon median
- Medicare services
- 57vs 35884% below
- Medicare patients
- 31vs 11172% below
- Part D claims
- 60vs 25276% below
Medians across 92 medical oncologists in Oregon with Dmand AI profiles that report each measure.
Dr. Grossmann's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Grossmann?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Grossmann and other medical oncologists in Oregon.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Kenneth Frederick Grossmann treated 31 Medicare patients in 2024, average age 72
CMS counts 31 Medicare patients who saw Dr. Grossmann in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have high blood pressure, and 58% have high cholesterol. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Grossmann's median patient age at 73, with 44% women.
Dr. Grossmann's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Grossmann's Medicare patients, 2024
- High blood pressure75%
- High cholesterol58%
- Diabetes35%
Share of Medicare patients with each condition. A patient can have several.
Dr. Grossmann's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women44%
- Men56%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Kenneth Frederick Grossmann wrote 111 Medicare Part D claims in 2024
In 2024, Dr. Grossmann wrote 111 Medicare Part D claims for 17 patients. 93% of them were for generic drugs. CMS names the drug for 60 of them, across 3 drugs with 11 or more claims each, at $281 in total drug cost. In 2021, CMS named 39 claims across 3 drugs.
Dr. Grossmann's Part D claims by kind of drug, 2024
- Generic103 claims93%
- Brand-name and other8 claims7%
Dr. Grossmann's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Grossmann's Part D claims, 2024
- Antipsychotics, patients 65 and over23%25 of 111 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2021 to 2024
- 2021
- 2024
- Claims for drugs CMS names
- 2021: 392024: 6054%
Drugs named by CMS: 3 in 2024, 3 in 2021.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Kenneth Frederick Grossmann has 43 publications on record
Dmand AI links 43 papers to Dr. Grossmann, published from 2012 to 2023. 2013 was the busiest year, with 4. The most frequent topics are Melanoma, Skin Neoplasms and Nivolumab. Dr. Grossmann has published most often in J Immunother Cancer. Dr. Grossmann's most frequent co-authors are Kari L. Kendra, MD, Christopher James Anker, MD and Tawnya L. Bowles, MD.
Dr. Grossmann's papers by year, 2013 to 2023
Topics Dr. Grossmann writes about most
- Melanoma
- Skin Neoplasms
- Nivolumab
- Antineoplastic Combined Chemotherapy Protocols
- Ipilimumab
- Neoplasm Metastasis
- Proto-Oncogene Proteins B-raf
- Programmed Cell Death 1 Receptor
Dr. Grossmann's most frequent co-authors
- Kari L. Kendra, MD7 shared papers
- Christopher James Anker, MD6 shared papers
- Tawnya L. Bowles, MD6 shared papers
Recent publications by Dr. Grossmann
See who Dr. Grossmann researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Grossmann works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Kenneth Frederick Grossmann has worked on 10 clinical trials
Dmand AI links Dr. Grossmann to 10 clinical trials, 4 of them phase 2 studies. 8 are still active or recruiting. Conditions studied include Melanoma, Nevi and Melanomas and Brain Neoplasms. National Cancer Institute (NCI) sponsors the most, 8.
Clinical trials with Dr. Grossmann by phase
- 1Phase 1: 1 trial
- 1Phase 1/2: 1 trial
- 4Phase 2: 4 trials
- 1Phase 2/3: 1 trial
- 3Phase 3: 3 trials
- NonePhase 4: no trials
Conditions in Dr. Grossmann's trials
- Melanoma
- Nevi and Melanomas
- Brain Neoplasms
- Mesothelioma
- Sjogren's Syndrome
Investigators on the most trials with Dr. Grossmann
- Sunandana Chandra, MD5 shared trials
- Kari L. Kendra, MD5 shared trials
- Sajeve Samuel Thomas, MD5 shared trials
Recent clinical trials with Dr. Grossmann
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer (opens in a new tab)
Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial (opens in a new tab)
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Kenneth Frederick Grossmann received $38,683 in industry payments from 2016 to 2025
CMS Open Payments shows 90 general payments to Dr. Grossmann from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 79% of the total. Bristol-Myers Squibb Company paid the most, $18,767. It also lists 2 research payments totaling $353 in 2016.
General payments to Dr. Grossmann by program year, 2016 to 2025
General payments to Dr. Grossmann by kind, 2016 to 2025
- Consulting fees$30,73579%
- Travel and lodging$4,31311%
- Food and beverage$3,6039%
- Education$320%
Companies that paid Dr. Grossmann the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Kenneth Frederick Grossmann graduated from Oregon Health Sciences University School of Medicine
Dr. Grossmann graduated from Oregon Health Sciences University School of Medicine in 2004.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Kenneth Frederick Grossmann's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Kenneth Frederick Grossmann
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Kenneth Frederick Grossmann's NPI number?
Dr. Kenneth Frederick Grossmann's NPI number is 1083827455. It was assigned on May 8, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Kenneth Frederick Grossmann?
Dr. Kenneth Frederick Grossmann is a medical oncologist in Portland, Oregon. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Kenneth Frederick Grossmann practice?
Dr. Grossmann practices at 4805 NE Glisan Street, Portland, OR 97213. Dr. Grossmann's primary practice is Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services.
What is Dr. Kenneth Frederick Grossmann's office phone number?
The practice phone on file for Dr. Grossmann is (503) 215-1111.
What is Dr. Kenneth Frederick Grossmann's medical license number?
Dr. Grossmann holds Utah license 6731091-1205.
Which hospitals is Dr. Kenneth Frederick Grossmann affiliated with?
Dr. Grossmann practices at Providence Portland Medical Center in Portland, Oregon.
What medical group is Dr. Kenneth Frederick Grossmann part of?
Dr. Grossmann is linked to Providence Medical Group, Oregon.
Does Dr. Kenneth Frederick Grossmann accept Medicare?
Yes. CMS data shows Dr. Grossmann billed Medicare for 57 services in 2024.
How many Medicare patients does Dr. Kenneth Frederick Grossmann see?
CMS counts 31 Medicare patients who saw Dr. Grossmann in 2024, with an average age of 72.
What services does Dr. Kenneth Frederick Grossmann bill to Medicare?
In 2024, Dr. Grossmann's most billed Medicare services were medicare service (G2211) and office visit, established patient (99215).
Show 6 more questionsShow fewer questions
Where did Dr. Kenneth Frederick Grossmann go to medical school?
Dr. Grossmann graduated from Oregon Health Sciences University School of Medicine in 2004.
What drugs does Dr. Kenneth Frederick Grossmann prescribe most?
In 2024 Medicare Part D data, Dr. Grossmann's most prescribed drugs by claims were Olanzapine, Dexamethasone and Prochlorperazine Maleate.
Has Dr. Kenneth Frederick Grossmann received payments from drug or device companies?
CMS Open Payments shows $38,683 in general payments to Dr. Grossmann from 9 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Kenneth Frederick Grossmann been practicing?
Dr. Grossmann graduated from medical school in 2004, 22 years ago.
Does Dr. Kenneth Frederick Grossmann do research?
Dmand AI links 43 publications to Dr. Grossmann, published from 2012 to 2023. Dr. Grossmann has worked on 10 clinical trials.
Who does Dr. Kenneth Frederick Grossmann publish with?
Dr. Grossmann's most frequent co-authors are Kari L. Kendra, MD (7 shared papers), Christopher James Anker, MD (6 shared papers) and Tawnya L. Bowles, MD (6 shared papers).
Selling to medical oncology practices?
See medical oncologists in Oregon by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card